Cargando…
Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates
BACKGROUND: Newborn screening (NBS) has been implemented for neonatal inborn disorders using various technology platforms, but false-positive and false-negative results are still common. In addition, target diseases of NBS are limited by suitable biomarkers. Here we sought to assess the feasibility...
Autores principales: | Huang, Xinwen, Wu, Dingwen, Zhu, Lin, Wang, Wenjun, Yang, Rulai, Yang, Jianbin, He, Qunyan, Zhu, Bingquan, You, Ying, Xiao, Rui, Zhao, Zhengyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862216/ https://www.ncbi.nlm.nih.gov/pubmed/35193651 http://dx.doi.org/10.1186/s13023-022-02231-x |
Ejemplares similares
-
Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China
por: Huang, Xinwen, et al.
Publicado: (2012) -
Variations of amino acid, free carnitine and acylarnitine profiles analysed by tandem mass spectrometry in newborns during their first four weeks of life
por: Hong, Fang, et al.
Publicado: (2015) -
Dynamic changes of metabolic characteristics in neonatal intrahepatic cholestasis caused by citrin deficiency
por: Zhang, Ting, et al.
Publicado: (2022) -
Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016) -
Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates
por: Lee, Hyunjoo, et al.
Publicado: (2019)